Evidence map›Paper›PMID 39738032›Full record

ArticleNature communications2024

DDX18 coordinates nucleolus phase separation and nuclear organization to control the pluripotency of human embryonic stem cells.

Xianle Shi, Yanjing Li, Hongwei Zhou, Xiukun Hou, Jihong Yang, Vikas Malik, Francesco Faiola, Junjun Ding, Xichen Bao, Miha Modic and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. A unified photosensitizer platform forbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Phase Separation in Chromatin Organization and Human Diseases.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Xianle Shi *Department of Medicine, Columbia Center for Human Development and Stem Cell Therapies, Columbia University Irving Medical Center, New York, NY, USA.
Yanjing Li *Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.ORCID 0000-0002-0747-6947
Hongwei Zhou *Department of Medicine, Columbia Center for Human Development and Stem Cell Therapies, Columbia University Irving Medical Center, New York, NY, USA.
Xiukun Hou *Department of Thyroid and Neck Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Jihong YangDepartment of Medicine, Columbia Center for Human Development and Stem Cell Therapies, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-2753-0939
Vikas MalikDepartment of Medicine, Columbia Center for Human Development and Stem Cell Therapies, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-9300-6414
Francesco FaiolaBlack Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Junjun DingBlack Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Xichen BaoGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.ORCID 0000-0003-0389-4233
Miha ModicThe Francis Crick Institute and University College London, London, UK.
Weiyu ZhangCollege of Life Sciences, Nankai University, Tianjin, China.
Lingyi ChenCollege of Life Sciences, Nankai University, Tianjin, China.ORCID 0000-0002-3695-3407
Syed Raza MahmoodDepartment of Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Effie ApostolouDepartment of Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-8111-0863
Feng-Chun YangDepartment of Molecular Medicine/Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0001-8524-4095
Mingjiang XuDepartment of Molecular Medicine/Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0002-7063-6253
Wei XieSchool of Life Sciences, Tsinghua University, Beijing, China.ORCID 0000-0003-2126-3849
Xin HuangDepartment of Medicine, Columbia Center for Human Development and Stem Cell Therapies, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0001-6778-8849
Yong ChenShanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China. yongchen@sibcb.ac.cn.ORCID 0000-0001-5857-6086
Jianlong WangDepartment of Medicine, Columbia Center for Human Development and Stem Cell Therapies, Columbia University Irving Medical Center, New York, NY, USA. jw3925@cumc.columbia.edu.ORCID 0000-0002-1317-6457

Funding

RNA-dependent chromatin targeting of TET2 for endogenous retrovirus control in pluripotent stem cellsR01HD095938 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WANG, JIANLONG · 2018 to 2022
$1.7M
Defining Novel Molecular Pathways to TotipotencyR01HD097268 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WANG, JIANLONG · 2018 to 2022
$1.7M
A Nucleolar Paradigm for Pluripotency of Human Embryonic Stem CellsR01HD114122 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jianlong Wang · 2024 to 2026
$1.6M
Transcriptional and Epigenetic Control of Pluripotency and Development by Zfp281R01GM129157 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WANG, JIANLONG · 2018 to 2021
$1.3M
The Regulatory R-loops in Pluripotency, Early Development, and Tissue HomeostasisR35GM154906 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Xin Huang · 2024 to 2026
$1.2M
Leica Stellaris 8 Confocal MicroscopeS10OD032447 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2022 to 2022
$652k
Decoding NSUN2-mediated translational control of pluripotent stem cellsR21HD116446 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, JIANLONG · 2024 to 2025
$452k
SINE-mediated Regulation of mRNA Epitranscriptome for Pluripotency Maintenance and DifferentiationR21HD106263 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HUANG, XIN · 2022 to 2023
$452k
NICHD NIH HHS R01 HD095938NICHD NIH HHS R01 HD097268NICHD NIH HHS R01 HD114122NICHD NIH HHS R21 HD106263NICHD NIH HHS R21 HD116446NIGMS NIH HHS R01 GM129157NIGMS NIH HHS R35 GM154906NIH HHS S10 OD032447U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) HD095938U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) HD097268U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) HD114122U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) R21HD116446U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM129157
6 · The paper itself

Abstract

Pluripotent stem cells possess a unique nuclear architecture characterized by a larger nucleus and more open chromatin, which underpins their ability to self-renew and differentiate. Here, we show that the nucleolus-specific RNA helicase DDX18 is essential for maintaining the pluripotency of human embryonic stem cells. Using techniques such as Hi-C, DNA/RNA-FISH, and biomolecular condensate analysis, we demonstrate that DDX18 regulates nucleolus phase separation and nuclear organization by interacting with NPM1 in the granular nucleolar component, driven by specific nucleolar RNAs. Loss of DDX18 disrupts nucleolar substructures, impairing centromere clustering and perinucleolar heterochromatin (PNH) formation. To probe this further, we develop NoCasDrop, a tool enabling precise nucleolar targeting and controlled liquid condensation, which restores centromere clustering and PNH integrity while modulating developmental gene expression. This study reveals how nucleolar phase separation dynamics govern chromatin organization and cell fate, offering fresh insights into the molecular regulation of stem cell pluripotency.

Indexed as

Cell NucleolusDEAD-box RNA HelicasesHeterochromatinHuman Embryonic Stem CellsNuclear ProteinsNucleophosminCell DifferentiationCell NucleusCentromereChromatinHumansPhase SeparationPluripotent Stem CellsChromatinDEAD-box RNA HelicasesHeterochromatinNPM1 protein, humanNuclear ProteinsNucleophosmin

Identifiers

PMID39738032
PMCPMC11685540

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.